Doctors have hit back at the publication of a study linking cholesterol-lowering statins to a higher cancer risk. A New England Journal of Medicine study angered doctors by linking Inegy, a combination of two drugs, to a 50 per cent rise in cancer cases. The story made headlines last week. However, doctors subsequently said the results were likely to be an anomaly and urged patients to keep taking their treatments.
What was the media coverage?
The comments from doctors were covered by the BBC News website. The initial study was covered by most of the national papers. The Daily Mail put the story on the front page, with the headline: ‘Cholesterol pill warning – Scientists raise fears of cancer link to statin used by thousands.’
Is there a danger of scaremongering when printing these types of stories?
Health stories in the national media can raise awareness of certain disease areas. For example, when singer Kylie Minogue spoke out about her breast cancer diagnosis, screenings at some hospitals increased by up to 25 per cent. Conversely parents started to boycott the triple MMR vaccine in the late 1990s following a (later disproven) link between MMR and autism.
Haven’t statins been in the press recently?
Yes. Statins hit the headlines in July following publication of a study in Neurology that suggested taking cholesterol-lowering statins may protect against dementia.
30,000 prescriptions in England and Wales in the past two years for Inegy
50% the amount by which Inegy was reported to raise the risk of cancer